By expenditures
| Name | Title | Type |
|---|---|---|
| Veronica Alvarez | Accounting Manager | Auditee |
| Linda Narciso | Audit Partner | Auditee |
| Bruce Foltz | Finance Director | Auditee |
| Robert Callanan | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 407460 | 2025 | 2026-07-20 | VASQUEZ & COMPANY LLP | $37.59M |
| 365413 | 2024 | 2025-09-02 | Vasquez & Company LLP | $40.40M |
| 340881 | 2023 | 2025-01-31 | Vasquez & Company LLP | $27.00M |
| 303639 | 2022 | 2024-04-16 | Cliftonlarsonallen LLP | $15.95M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 407460 | 2025 | 2026-07-20 | 1224036 | 2025-005 | Material Weakness | Yes | G |
| 407460 | 2025 | 2026-07-20 | 1224035 | 2025-004 | Material Weakness | Yes | B |
| 407460 | 2025 | 2026-07-20 | 1224034 | 2025-003 | Material Weakness | Yes | L |
| 407460 | 2025 | 2026-07-20 | 1224033 | 2025-002 | Material Weakness | Yes | H |
| 407460 | 2025 | 2026-07-20 | 1224032 | 2025-001 | Material Weakness | Yes | L |
| 365413 | 2024 | 2025-09-02 | 1151829 | 2024-003 | - | - | L |
| 365413 | 2024 | 2025-09-02 | 1151828 | 2024-002 | Material Weakness | Yes | I |
| 365413 | 2024 | 2025-09-02 | 1151827 | 2024-001 | Material Weakness | - | L |
| 365413 | 2024 | 2025-09-02 | 575387 | 2024-003 | - | - | L |
| 365413 | 2024 | 2025-09-02 | 575386 | 2024-002 | Material Weakness | Yes | I |
| 365413 | 2024 | 2025-09-02 | 575385 | 2024-001 | Material Weakness | - | L |
| 340881 | 2023 | 2025-01-31 | 1097451 | 2023-004 | Material Weakness | Yes | L |
| 340881 | 2023 | 2025-01-31 | 1097450 | 2023-003 | Material Weakness | Yes | I |
| 340881 | 2023 | 2025-01-31 | 1097449 | 2023-002 | Material Weakness | Yes | I |
| 340881 | 2023 | 2025-01-31 | 1097448 | 2023-001 | Material Weakness | - | L |
| 340881 | 2023 | 2025-01-31 | 521009 | 2023-004 | Material Weakness | Yes | L |
| 340881 | 2023 | 2025-01-31 | 521008 | 2023-003 | Material Weakness | Yes | I |
| 340881 | 2023 | 2025-01-31 | 521007 | 2023-002 | Material Weakness | Yes | I |
| 340881 | 2023 | 2025-01-31 | 521006 | 2023-001 | Material Weakness | - | L |
| 303639 | 2022 | 2024-04-16 | 969841 | 2022-007 | Significant Deficiency | - | L |
| 303639 | 2022 | 2024-04-16 | 969840 | 2022-006 | Significant Deficiency | - | I |
| 303639 | 2022 | 2024-04-16 | 969839 | 2022-006 | Significant Deficiency | - | I |
| 303639 | 2022 | 2024-04-16 | 969838 | 2022-005 | Material Weakness | - | I |
| 303639 | 2022 | 2024-04-16 | 393399 | 2022-007 | Significant Deficiency | - | L |
| 303639 | 2022 | 2024-04-16 | 393398 | 2022-006 | Significant Deficiency | - | I |
| 303639 | 2022 | 2024-04-16 | 393397 | 2022-006 | Significant Deficiency | - | I |
| 303639 | 2022 | 2024-04-16 | 393396 | 2022-005 | Material Weakness | - | I |